Hartford Investment Management Co (HIMCO)’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-101,723
Closed -$295K 736
2018
Q4
$295K Hold
101,723
0.01% 578
2018
Q3
$268K Sell
101,723
-6,787
-6% -$16.7K 0.01% 642
2018
Q2
$254K Buy
+108,510
New +$303K 0.01% 677
2017
Q1
Sell
-14,900
Closed -$32K 663
2016
Q4
$32K Sell
14,900
-100
-0.7% -$279 ﹤0.01% 628
2016
Q3
$50K Buy
15,000
+1,200
+9% +$3.81K ﹤0.01% 612
2016
Q2
$43K Buy
13,800
+400
+3% +$1.33K ﹤0.01% 616
2016
Q1
$45K Hold
13,400
﹤0.01% 607
2015
Q4
$47K Buy
+13,400
New +$56.1K ﹤0.01% 616
2014
Q3
Sell
-52,450
Closed -$508K 803
2014
Q2
$508K Sell
52,450
-500
-0.9% -$4.46K 0.01% 570
2014
Q1
$440K Buy
52,950
+3,800
+8% +$32.6K 0.01% 612
2013
Q4
$415K Buy
+49,150
New +$414K 0.01% 633

Other funds holding PDLI

Hartford Investment Management Co (HIMCO)'s PDLI Position: Q1 2019 in Review

Hartford Investment Management Co (HIMCO) sold out of PDL BioPharma, Inc. (PDLI) in Q1 2019, closing a stake of 101,723 shares — an estimated $295K sold.

Hartford Investment Management Co (HIMCO) first reported a position in PDLI in Q4 2013 and held it in 11 quarters. The position peaked at $508K in Q2 2014. 157 funds tracked by Wall St. Rank hold PDLI as of Q1 2019.

  • Hartford Investment Management Co (HIMCO) reported no remaining PDL BioPharma, Inc. position as of Q1 2019 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 101,723 PDL BioPharma, Inc. shares in Q1 2019, an estimated $295K.
  • Hartford Investment Management Co (HIMCO) first reported a position in PDL BioPharma, Inc. in Q4 2013 and held it in 11 quarters.
  • Hartford Investment Management Co (HIMCO)'s PDL BioPharma, Inc. position peaked at $508K in Q2 2014.
  • 157 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2019.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q1 2019, filed 29 Apr 2019.